Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid‐range ejection fraction [PDF]
Aims Current evidence about the effect of angiotensin receptor blocker (ARB) on the outcome of heart failure with mid‐range ejection fraction (HFmrEF) is lacking.
Bin Wang +6 more
doaj +2 more sources
High‐Intensity Interval Training Is Associated With Improved 10‐Year Survival by Mediating Left Ventricular Remodeling in Patients With Heart Failure With Reduced and Mid‐Range Ejection Fraction [PDF]
Background This study aimed to assess the left ventricular (LV) remodeling response and long‐term survival after high‐intensity interval training (HIIT) in patients with various heart failure (HF) phenotypes during a 10‐year longitudinal follow‐up ...
Chih‐Chin Hsu +5 more
doaj +2 more sources
The European society of cardiology guideline for the diagnosis and treatment of acute and chronic heart failure (CHF) in 2016 identified a new group of patients with mid-range left ventricular ejection fraction (LVEF) with reference interval in the range
N. T. Vatutin +2 more
doaj +2 more sources
Predictors of cardiac function in acute heart failure patients with mid‐range ejection fraction: AURORA study [PDF]
Aim The factors correlated with prognosis in heart failure with mid‐range ejection fraction (HFmrEF) is unclear, especially for acute heart failure (AHF) with HFmrEF.
Kyosuke Yanagawa +14 more
doaj +2 more sources
Heart failure with mildly reduced ejection fraction: emerging frontiers in clinical characteristics, prognosis, and treatment [PDF]
Heart failure (HF) is a complex clinical syndrome resulting from the impairment of ventricular filling or ejection of blood or both, leading to considerable morbidity and mortality. Based on left ventricular ejection fraction (LVEF), the 2016 European
Zhi Shang, Xinyu Wang, Wei Gao
doaj +1 more source
Changes in the Left Ventricular Ejection Fraction and Outcomes in Hospitalized Heart Failure Patients with Mid-range Ejection Fraction: A Prospective Observational Study. [PDF]
東京女子医科大学博士(医学)博士(医学) 甲第745号(主論文の要旨、要約、審査結果の要旨、本文),著者名:Kei TSUKAMOTO, Atsushi SUZUKI, Tsuyoshi SHIGA, Kotaro ARAI, Nobuhisa HAGIWARA,タイトル:Changes in the Left Ventricular Ejection Fraction and Outcomes in Hospitalized Heart Failure Patients with Mid-range ...
Tsukamoto K +4 more
europepmc +3 more sources
Тhe uncharted middle ground – when the patient asks, but the guideliness don’t answer [PDF]
Heart failure takes up an increasing portion of everyday cardiology practice. The accumulation of knowledge about the range of phenotypes and the therapeutic responses across the spectrum of heart failure leads to dynamic reconsideration of the best ...
Iskra Bayraktarova, Tzvetana Katova
doaj +3 more sources
The value of IGF-1 and IGFBP-1 in patients with heart failure with reduced, mid-range, and preserved ejection fraction [PDF]
Background: Previous studies have reported inconsistent results regarding the implications of deranged insulin-like growth factor 1 (IGF-1)/insulin-like growth factor-binding protein 1 (IGFBP-1) axis in patients with heart failure (HF).
Tse, Gary +5 more
core +1 more source
Treatment of Heart Failure with Mid-Range Ejection Fraction: What Is the Evidence. [PDF]
In this review, we briefly outline our current knowledge on the epidemiology, outcomes, and pathophysiology of heart failure (HF) with mid-range ejection fraction (HFmrEF), and discuss in more depth the evidence on current treatment options for this ...
Koufou EE +3 more
europepmc +2 more sources
Aims This study aimed to determine the impact of heart failure (HF) on clinical outcomes in patients with atrial fibrillation (AF). Methods and results We analysed data from Polish participants of the EURObservational Research Programme‐AF General Long ...
Monika Budnik +13 more
doaj +1 more source

